Lexicon Pharmaceuticals
LXRX
LXRX
104 hedge funds and large institutions have $354M invested in Lexicon Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 37 increasing their positions, 34 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
0.68% less ownership
Funds ownership: 77.83% → 77.15% (-0.68%)
1% less funds holding
Funds holding: 105 → 104 (-1)
7% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 15
Holders
104
Holding in Top 10
1
Calls
$374K
Puts
$286K
Top Buyers
| 1 | +$815K | |
| 2 | +$744K | |
| 3 | +$618K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$285K |
| 5 |
Natixis Advisors
Boston,
Massachusetts
|
+$213K |
Top Sellers
| 1 | -$2.8M | |
| 2 | -$2.01M | |
| 3 | -$475K | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$469K |
| 5 |
D.E. Shaw & Co
New York
|
-$333K |